BSC
TWST icon

BOLTON SECURITIES CORPORATION’s Twist Bioscience TWST Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.5K Buy
+200
New +$8.97K ﹤0.01% 1629
2025
Q3 		$5.63K Buy
+200
New +$6.06K ﹤0.01% 1680
2025
Q1 		$7.85K Buy
+200
New +$9.01K ﹤0.01% 1482

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.5B AUM 50.54% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EdgePoint Investment Group
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's TWST Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in Twist Bioscience (TWST) in Q1 2026: 200 shares worth $9.5K. The stake represents ﹤0.01% of the portfolio and ranks #1629 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in TWST as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in TWST in Q1 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 200 shares of Twist Bioscience worth $9.5K as of Q1 2026.
  • Twist Bioscience was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • Twist Bioscience made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1629 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Twist Bioscience in Q1 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.